SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-031811
Filing Date
2024-07-01
Accepted
2024-06-28 19:08:24
Documents
19
Period of Report
2024-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20031755x4_8k.htm   iXBRL 8-K 39327
2 EXHIBIT 1.1 ny20031755x4_ex1-1.htm EX-1.1 461293
3 EXHIBIT 4.1 ny20031755x4_ex4-1.htm EX-4.1 93308
4 EXHIBIT 4.2 ny20031755x4_ex4-2.htm EX-4.2 77185
5 EXHIBIT 5.1 ny20031755x4_ex5-1.htm EX-5.1 15550
6 EXHIBIT 99.1 ny20031755x4_ex99-1.htm EX-99.1 12215
10 ny20031755x4_ex5-1img01.jpg GRAPHIC 2596
  Complete submission text file 0001140361-24-031811.txt   995689

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eltx-20240628.xsd EX-101.SCH 3859
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltx-20240628_lab.xml EX-101.LAB 22690
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltx-20240628_pre.xml EX-101.PRE 16548
23 EXTRACTED XBRL INSTANCE DOCUMENT ny20031755x4_8k_htm.xml XML 4225
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 241087392
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)